Session Details

Symposium 4

Sun. Sep 28, 2025 9:30 AM - 12:00 PM JST
Sun. Sep 28, 2025 12:30 AM - 3:00 AM UTC
Room 1(1F Main Hall 1/2A)
Chair:Wakaba Fukushima, Takuo Mizukami

[SY4-01]WHOによるワクチン推奨株の選定の過程と最近の季節性インフルエンザウイルスの動向について

*Shinji Watanabe1 (1. Influenza Research Center, National Institute of Innfectious Diseases, Japan Institute for Health Security)

[SY4-02]従来型の不活化インフルエンザワクチンの有効性と安全性

*Satoko Ohfuji1 (1. Department of Public Health, Osaka Metropolitan University Graduate School of Medicine)

[SY4-03]Nasal live attenuated influenza vaccine: Review of the first season in Japan

*Toshihiro Tanaka1 (1. Department of Pediatrics, Shizuoka Kose Hospital, JAPAN)

[SY4-04]Foundational Study on Intranasal Inactivated Influenza Vaccines

*Hideki Hasegawa1 (1. National Institute of Infectious Diseases, Influenza Research Center)

[SY4-05]高齢者向けに開発・国内承認された高用量インフルエンザワクチンについて

*Takeshi Arashiro1 (1. Sanofi Vaccines Medical)

[SY4-06]An mRNA vaccine -Insights and challenges of a mRNA vaccine modality from research and development of COVID-19 Vaccine DS-5670-

*Nao Jonai1 (1. Vaccine Research Laboratories, R&D Division)

[SY4-07]細胞培養インフルエンザワクチンの開発研究 〜迅速かつ安定的なワクチン供給を目指して〜

*Hitoshi Takahashi1 (1. Japan Institute for Health Security, National Institute of Infectious Diseases, Influenza Research Center)

[SY4-08]交差防御性に優れたインフルエンザワクチン開発研究の現状

*Takuya Yamamoto1 (1. Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition)

総合討論